EUVIMEDEUVIMED entdecken
Crossref

68Ga-granzyme B (68Ga-NOTA-GSI) PET/CT for predicting immunotherapy response and progression free survival in NSCLC

Ziyi Yang, Zhihuang Hu, Xiaoping Xu, Qiufang Liu, Zhenhua Wu, Huijie Wang, Jianping Zhang, Jindian Li, Jialei Wang, Shaoli Song

European Journal of Nuclear Medicine and Molecular Imaging · 2026-11 · 53 (13) · 8297-8308

DOI: 10.1007/s00259-026-08097-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, online erschienen am 14.08.2026. Verfasst von Ziyi Yang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Shanghai Cancer Center, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Heterocyclic Compounds, Immunotherapy, Lung Neoplasms. Die Arbeit nennt 31 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungHeterocyclic CompoundsImmunotherapyLung NeoplasmsPositron Emission Tomography Computed TomographyAgedFemaleHumansMaleMiddle AgedGallium RadioisotopesProgression-Free SurvivalTreatment OutcomeHeterocyclic Compounds, 1-Ring

Stichwörter der Autor:innen

Immune responseNomogramNon‑small cell lung cancerProgression‑free survival⁶⁸Ga-NOTA-GSI PET/CT

Substanzen

1,4,7-triazacyclononane-N,N',N''-triacetic acidGallium RadioisotopesHeterocyclic CompoundsHeterocyclic Compounds, 1-Ring

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Shanghai Cancer Center, Fudan University, Shanghai, China.
  • Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Shanghai Engineering Research Center of Molecular Imaging Probes, Shanghai, China.
  • Key Laboratory of Nuclear Physics and Ion-Beam Application, MOE, Fudan University, Shanghai, China.
  • Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China. wangjialei@shca.org.cn.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Yang, Z., Hu, Z., Xu, X., Liu, Q., Wu, Z., Wang, H., Zhang, J., Li, J., Wang, J., & Song, S. (2026). 68Ga-granzyme B (68Ga-NOTA-GSI) PET/CT for predicting immunotherapy response and progression free survival in NSCLC. European Journal of Nuclear Medicine and Molecular Imaging, 53(13), 8297-8308. https://doi.org/10.1007/s00259-026-08097-6

Vancouver

Yang Z, Hu Z, Xu X, Liu Q, Wu Z, Wang H, et al. 68Ga-granzyme B (68Ga-NOTA-GSI) PET/CT for predicting immunotherapy response and progression free survival in NSCLC. European Journal of Nuclear Medicine and Molecular Imaging. 2026;53(13):8297-8308. doi:10.1007/s00259-026-08097-6

BibTeX
@article{Yang2026,
  author = {Yang, Ziyi and Hu, Zhihuang and Xu, Xiaoping and Liu, Qiufang and Wu, Zhenhua and Wang, Huijie and Zhang, Jianping and Li, Jindian and Wang, Jialei and Song, Shaoli},
  title = {68Ga-granzyme B (68Ga-NOTA-GSI) PET/CT for predicting immunotherapy response and progression free survival in NSCLC},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2026},
  volume = {53},
  number = {13},
  pages = {8297--8308},
  doi = {10.1007/s00259-026-08097-6}
}
Kostenlos starten →